Table 2.
Cell type | General function | Actions in inflammation resolution | Ref. |
---|---|---|---|
Neutrophils |
Phagocytosis Pro-inflammation NETosis |
Accelerate cytokines and chemokines secretion Apoptosis NETosis Egress to Lymph node |
[7, 51, 55] |
Macrophages |
PRR Phagocytosis Efferocytosis |
M2 formation Effercytosis Secrete pro-inflammation cytokines, such as IL-10, TGF-β Egress to Lymph nodes Promote SPMs, including resolvins, maresins, protectins formation |
[80, 81, 191] |
Eosinophils |
Phagocytosis Cytotoxic substances |
IL-4, IL-13 secretion Lipoxin A4 production |
[46] |
Mast cells | Secretion of vasoactive substances | Mediators secretion | [51] |
DCs |
Sensing DAMPs PRR |
TGF-b, IL-10 secretion Inhibits migration Maintain the homeostasis after inflammation resolute |
[20, 21] |
ILC2 |
Produce type 2 cytokines Express surface markers and receptors for chemokine |
Inhibits IL-13 secretion, Express the chemokine receptors CXCR6 and CCR9 IL-25, IL-33, and thymic stromal lymphopoietin (TSLP) to induce inflammation formation and eosinophilic infiltration |
[115, 117, 192] |
Epithelial cells |
Physical barrier Mucociliary clearance |
Maintain mucosal integrity and to modulate local immune responses Decrease and limit pro-inflammatory mediators and proteins Increases proliferation after acid injury and promote tissue repair Immune regulator |
[24, 193] |
Endothelial cells | Regulation transduction and exudation |
Inhibits TNF-a, IL-1b and IL-18 secretion Blocks the generation of reactive oxygen species |
[51] |
Fibroblasts |
Tissue support Cytokine secretion |
Growth factors inducement Inhibits CTGF-induced proliferation |
[46, 194] |